Skip to main content
. Author manuscript; available in PMC: 2015 Nov 1.
Published in final edited form as: Clin Cancer Res. 2014 Sep 4;20(21):5392–5402. doi: 10.1158/1078-0432.CCR-14-0968

Figure 3.

Figure 3

Relative changes (mean and standard deviation) in the number of Tregs (A) and TIM3-expressing CD8+T cells (C) with treatment. Progression-free survival of patients with post-treatment Treg (B) and TIM3+ CD8+T cell (D) numbers above and below the median.